CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

M15 General Principles for Model-Informed Drug Development

RegulatoryNeutral
AI Analysis

Summary

FDA released M15 guidance on General Principles for Model-Informed Drug Development, providing regulatory framework and recommendations for pharmaceutical companies using MIDD approaches in drug development.

Importance:2/10
Sentiment:
0.00
FDA GuidanceModel-Informed Drug DevelopmentMIDDRegulatory Framework

Read the original article

Published by FDA Drugs (New Approvals & NDA) on June 3, 2026 1:47 PM

Read Original